Next |
home / stock / vtrs / vtrs message board
Subject | By | Source | When |
---|---|---|---|
$VTRS reports 4Q22 resultsissues 2023 guidance: | DewDiligence | investorshub | 02/27/2023 5:04:40 PM |
Nothing that's been publicly disclosed. | DewDiligence | investorshub | 02/27/2023 5:03:45 PM |
VTRS names new CEO: | DewDiligence | investorshub | 02/27/2023 5:03:22 PM |
VTRS anything going on? Related to $RVNC? eom | procqw2 | investorshub | 10/11/2022 3:02:32 PM |
VTRS anything going on? Related to $RVNC? eom | procqw2 | investorshub | 10/11/2022 3:02:28 PM |
VIATRIS - FDA APPROVES GENERIC FORM OF SYMBICORT | TRUISM | investorshub | 03/15/2022 10:25:40 PM |
VTRS sells JV stake in Humira/Enbrel/Eylea-biosimilars portfolio to Biocon | DewDiligence | investorshub | 02/28/2022 2:59:05 PM |
FDA approves $VTRS generic Restasisthe first US generic | DewDiligence | investorshub | 02/02/2022 7:39:33 PM |
sees u r right, good sign | p0 | investorshub | 01/03/2022 4:05:22 PM |
This one should be trading over $15.00, some | trendzone | investorshub | 12/30/2021 10:01:29 PM |
Fed.Cir. holds certain SNY patents, involving Lantus insulin | north40000 | investorshub | 12/29/2021 5:42:11 PM |
Shorts are getting closer and closer to getting | trendzone | investorshub | 12/23/2021 4:21:53 PM |
Viatris ($VTRS) could combine biosimilars with Biocon and | trendzone | investorshub | 12/09/2021 7:45:35 PM |
He probably would do that if you subscribe | trendzone | investorshub | 12/03/2021 1:52:54 PM |
Clay eat my sack | NSPAT | investorshub | 09/29/2021 4:54:17 PM |
Viatris Inc. Announces Inaugural Quarterly Dividend | TechWhiz | investorshub | 05/11/2021 9:32:59 PM |
* * $VTRS Video Chart 05-10-2021 * * | ClayTrader | investorshub | 05/10/2021 9:27:49 PM |
hm, I bought in at 43 or so, | p0 | investorshub | 04/12/2021 6:28:18 PM |
$13 seems like a great buy-in price for | jimmy44 | investorshub | 03/03/2021 7:13:00 PM |
Viatris $CEO Heather Bresch is the daughter of | Penny City Sharps | investorshub | 02/11/2021 9:23:13 PM |
News, Short Squeeze, Breakout and More Instantly...
U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation PR Newswire PITTSBURGH , July 2, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that the Antitrust Divisi...
Viatris Named to TIME's World's Most Sustainable Companies 2024 List PR Newswire PITTSBURGH , June 25, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to the inaugural edition of TIME's W...
2024-06-15 14:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...